A Phase 2 study for the use of Botox in patients with migraine headaches

  • sponsor
    Aeon Biopharma
Updated on 12 August 2022


This study is for the possible prevention of migraine headaches with Botox (Purified Neurotoxin Complex) injections.


A randomized, multicenter, double-blind, placebo-controlled, Phase 2 study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the prevention of migraine headache.

Condition Migraine (Adult), migraine
Clinical Study IdentifierTX269372
SponsorAeon Biopharma
Last Modified on12 August 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note